Cargando...
Autologous cytokine‐induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome
The primary objective of this study was to evaluate the safety and clinical efficacy of autologous cytokine‐induced killer (CIK) cells combined with cyclophosphamide in the treatment of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome patients. We...
Guardado en:
| Publicado en: | Clin Exp Immunol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778094/ https://ncbi.nlm.nih.gov/pubmed/26660736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12755 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|